Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment

被引:796
作者
Lenardo, M [1 ]
Chan, FKM [1 ]
Hornung, F [1 ]
McFarland, H [1 ]
Siegel, R [1 ]
Wang, J [1 ]
Zheng, LX [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
death; cytokine; lymphokine; Fas/APO-1/CD95; Bcl-2; propriocidal; feedback; caspase; tumor necrosis factor; receptor; Autoimmune Lymphoproliferative Syndrome;
D O I
10.1146/annurev.immunol.17.1.221
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apoptosis of mature T lymphocytes preserves peripheral homeostasis and tolerance by countering the profound changes in the number and types of T cells stimulated by diverse antigens. T cell apoptosis occurs in at least two major forms: antigen-driven and lymphokine withdrawal. These forms of death are controlled in response to local levels of IL-2 and antigen in a feedback mechanism termed propriocidal regulation. Active antigen-driven death is mediated by the expression of death cytokines such as FasL and TNF. These death cytokines engage specific receptors that assemble caspase-activating protein complexes. These signaling complexes tightly regulate cell death but are vulnerable to inherited defects. Passive lymphokine withdrawal death may result from the cytoplasmic activation of caspases that is regulated by mitochondria and the Bcl-2 protein. The human disease, Autoimmune Lymphoproliferative Syndrome (ALPS) is due to dominant-interfering mutations in the Fas/APO-1/CD95 receptor and other components of the death pathway. The study of ALPS patients reveals the necessity of apoptosis for preventing autoimmunity and allows the genetic investigation of apoptosis in humans. Immunological, cellular, and molecular evidence indicates that throughout the life of a T cell, apoptosis may be evoked in excessive, harmful, or useless clonotypes to preserve a healthy and balanced immune system.
引用
收藏
页码:221 / 253
页数:33
相关论文
共 347 条
[1]   Die and let live: Eliminating dangerous lymphocytes [J].
Abbas, AK .
CELL, 1996, 84 (05) :655-657
[2]   FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[3]   Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL [J].
AlexanderMiller, MA ;
Leggatt, GR ;
Sarin, A ;
Berzofsky, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :485-492
[4]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[5]   Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection? [J].
Allison, J ;
Seino, K ;
Yagita, H .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 19 (03) :311-322
[6]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[7]   TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY MEMBERS AND THEIR LIGANDS [J].
ARMITAGE, RJ .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :407-413
[8]   Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors [J].
Armstrong, RC ;
Aja, T ;
Xiang, JL ;
Gaur, S ;
Krebs, JF ;
Hoang, K ;
Bai, X ;
Korsmeyer, J ;
Karanewsky, DS ;
Fritz, LC ;
Tomaselli, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16850-16855
[9]   Proteolysis and the biochemistry of life-or-death decisions [J].
Ashkenas, J ;
Werb, Z .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :1947-1951
[10]   A DIFFERENTIAL-AVIDITY MODEL FOR T-CELL SELECTION [J].
ASHTONRICKARDT, PG ;
TONEGAWA, S .
IMMUNOLOGY TODAY, 1994, 15 (08) :362-366